Lukang Pharmaceutical (600789): Feasibility Analysis Report of Lukang Pharmaceutical's 2021 Annual Allotment Raised Funds (Revised Draft) CFi.CN Zhongcai Network

  • Post date April 19, 2022 — 20:10 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

002786 300170 300713 ADD Industry China Shipbuilding Industry Group Power Citic Securities Fujian Funeng Hand Enterprise Solutions Perfect Group Corp. Shandong Lukang Pharmaceutical Shenzhen Silver Basis Technology Shenzhenrease Technology Xinjiang Sayram Modern Agriculture Crime, Law, Justice Law Regulations Earnings Restructuring, Recapitalisation Management Strategy, Marketing Annual, Special Corporate Meeting Board Of Directors Research, Development Health, Beauty Product Pharmaceutical Synthetic, Plastic Chemicals Construction, Property Water Supply Financial, Business Service Insurance Economic Growth Market, Exchange Loans Securities Small, Medium Enterprise Sales Channels Economy, Business, Finance Environment

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data